Multiple musculoskeletal conditions · Review · 2022
How do clinicians use shockwave for tendon, bone and joint problems?
This guide for clinicians explains how shockwave is used for tendon, bone and joint problems and for muscle stiffness (spasticity). It compares focused and radial waves and suggests 3–5 sessions, usually a week apart, without a numbing injection. It also covers safety and training.
- sessions typically suggested, about a week apart
- 3–5
- wave types explained: focused and radial
- 2
- areas covered: tendons, bone, joints, muscle stiffness
- 4
Good to know: Practice advice, not a new study. It suggests aiming the treatment at the most painful spot.
Tenforde AS, Borgstrom HE, DeLuca S, et al. PM & R : the Journal of Injury, Function, and Rehabilitation, 2022 · Read the paper ↗
How this study worked
Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.
What the trials used
- Modality
- Focused, radial or combined shockwave; focused waves converge at depth, while radial pressure is maximal at the applicator and attenuates with depth.
- Typical schedule in article table
- Table 3: typically 3–5 treatments, generally one week apart. Table 7 prints: "Generally 3-5 sessions with the exception of treatment for bone and spasticity at 1 week intervals." These are practice recommendations in this narrative report.
- Energy discussion
- Approximate EFD bands in the article: low <0.08–0.10 mJ/mm² (printed "<0.08–10", evidently 0.10); medium 0.08–0.28; high >0.29–0.60. The source says literature cutoffs vary.
- Anesthesia and targeting
- The article recommends no local anesthetic and clinical focusing at maximal pain sites; it discusses imaging as useful for selected bone/deep targets.
Who took part
No participants: guidance for clinicians and trainees on using shockwave in outpatient care for tendon, bone, joint and muscle-stiffness problems.
Side effects
Possible effects listed: pain, redness, bruising, nerve tingling, swelling, headache and migraine. It cites two Achilles tendon tears within two weeks of focused treatment, in women over 60.
All the numbers and the full appraisal
Every reported result
What the full paper reports.
No original sample. Narrative practice guidance for outpatient musculoskeletal clinicians; clinical topics include tendon/fascia, bone, joints and neurologic spasticity.
Practice-management guidance on clinical application, training and precautions1 reported outcome
Practice-management guidance on clinical application, training and precautions
Narrative recommendations; no clinical effect unit
The paper offers proposed clinical and training practices, not a trial outcome or comparative effect estimate.
Analysis details and source
No original outcome analysis. Cited findings, such as the two Achilles ruptures, remain attributed to the cited trial (Costa et al., reference 30) and are not incidence estimates.
How treatment was delivered
Focused, radial or combined shockwave; focused waves converge at depth, while radial pressure is maximal at the applicator and attenuates with depth.
Table 3: typically 3–5 treatments, generally one week apart. Table 7 prints: "Generally 3-5 sessions with the exception of treatment for bone and spasticity at 1 week intervals." These are practice recommendations in this narrative report.
Approximate EFD bands in the article: low <0.08–0.10 mJ/mm² (printed "<0.08–10", evidently 0.10); medium 0.08–0.28; high >0.29–0.60. The source says literature cutoffs vary.
The article recommends no local anesthetic and clinical focusing at maximal pain sites; it discusses imaging as useful for selected bone/deep targets.
Potential local effects include pain, erythema, bruising, hematoma, nerve irritation/paresthesia and superficial edema; headache and migraine are listed as systemic effects. Two Achilles ruptures within two weeks after initial focused treatment in women >60 are cited from Costa et al. (reference 30, a randomized placebo-controlled trial), with no denominator in this article.
This is a narrative practice-management article and does not report systematic-review methods or original comparative patient outcomes.
The authors state that device type and multiple treatment parameters differ across studies; mechanisms remain uncertain and protocol standardization is needed.
The authors note that safety evidence is difficult to assess for patients excluded from studies, including some anticoagulated patients or those with devices.
Disclosures report support from Uniform Health Services and DJO Global for research involving photobiomodulation and shockwave in Achilles tendinopathy.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- This is a narrative practice-management article and does not report systematic-review methods or original comparative patient outcomes.
- The authors state that device type and multiple treatment parameters differ across studies; mechanisms remain uncertain and protocol standardization is needed.
- The authors note that safety evidence is difficult to assess for patients excluded from studies, including some anticoagulated patients or those with devices.
- Disclosures report support from Uniform Health Services and DJO Global for research involving photobiomodulation and shockwave in Achilles tendinopathy.
Source-linked critical reading
Narrative practice review
Technical source record
Complete parsed full-text XML and raw XML article structure reviewed: all 16 section records, nine tables and their captions/cells, and Figure 1 caption. The figure image was not available for visual inspection. No supplement was listed.
This article explains how clinicians may think about shock-wave treatment, its possible side effects and training. It does not establish how much benefit a patient should expect or a single best treatment schedule. Suitability and precautions depend on the condition, device and individual health factors.
What practical guidance can help outpatient musculoskeletal clinicians apply extracorporeal shock-wave therapy, counsel patients, train learners and identify areas requiring further evidence?
Narrative practice-management review and proposed educational framework. It summarizes mechanisms, clinical applications, procedure setup, training, safety and future research; it does not report a systematic search, pooled clinical estimate or original patient cohort.
No participants were enrolled for this article. Its clinical discussion spans tendinopathies, plantar fasciopathy, bone stress injury/delayed union/osteonecrosis, joint conditions and spasticity. Its curricular guidance concerns PM&R residents and fellows.
The article distinguishes focused ESWT (pressure waves converge at depth; electrohydraulic, electromagnetic or piezoelectric generation) from radial pressure waves (maximal pressure at applicator, attenuating with depth), and discusses combined treatment. Table 3 states typical spacing of one week and 3–5 sessions; it recommends no local anesthetic and clinical focusing. It describes energy categories as approximate and notes cutoffs vary: low (<0.08–0.10 mJ/mm²; printed "<0.08–10"), medium (0.08–0.28), high (>0.29–0.60). These are article guidance, not validated universal prescriptions.
The report recommends condition-specific comparison with sham/placebo in future research. It does not analyze one comparator or claim one treatment contrast.
Qualitatively, the article presents condition-specific clinical applications and proposed mechanisms, then proposes counseling, procedural and educational practices. It does not provide a patient-level outcome dataset or effect estimate.
No new comparative estimate is reported. The article cites prior trials and reviews but its tables of mechanisms and training milestones are not evidence syntheses of treatment effects.
Table 8 lists local pain, erythema, bruising, hematoma, nerve irritation/numbness/tingling and superficial edema, plus headache and migraine. The narrative describes two Achilles ruptures within two weeks after initial focused ESWT in women over 60, as reported in a cited randomized placebo-controlled trial (Costa et al.). This is a cited safety signal, not an incidence estimate. The authors discuss contraindications and caution factors, including pregnancy, active infection, tumor near treatment area for focused ESWT, high-energy exposure to sensitive structures, coagulopathy, anticoagulants, NSAIDs, recent steroid injection and implanted cardiac devices. Guidance may change; the text notes disagreement/evolution in contraindication recommendations.
The article is a practice-management narrative with no systematic methods or original comparative dataset. The mechanisms are proposed and not fully established. It notes substantial variation among devices, energy, impulse count, frequency, sessions and analgesia. Some contraindication evidence is limited because relevant patients are excluded from studies. A single Figure 1 is a positioning photograph; it was not visually available in the retrieved XML. Disclosures report research support from Uniform Health Services and DJO Global device support to one author.
The article offers clinician-oriented considerations rather than proof of efficacy for an individual diagnosis. It advises clinical focusing over painful sites, counseling about procedural pain and transient analgesia, and load management after treatment. Activity advice is individualized; structured condition-specific protocols are outside scope.
The authors call for standardized diagnosis-specific techniques, validated patient-reported pain and function measures, and higher-level comparisons of radial, focused or combined treatment with sham/placebo. They also call for study of ESWT with orthobiologic injections and development of residency/fellowship curricula.
Read the original article.
Best practices for extracorporeal shockwave therapy in musculoskeletal medicine: Clinical application and training consideration.
Tenforde AS, Borgstrom HE, DeLuca S, McCormack M, Singh M, Hoo JS, Yun PH. · PM & R : the journal of injury, function, and rehabilitation · 2022
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →